Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian S Dobs

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 20, 2015
Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected MenKerunne S Ketlogetswe, Rebeccah McKibben, Lisa P Jacobson, et al.
AIDS (London, England)|January 10, 2014
Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected menKerunne S Ketlogetswe, Wendy S Post, Xiuhong Li, et al.
The American Journal of Cardiology|February 3, 2016
Comparison of Insulin Resistance to Coronary Atherosclerosis in Human Immunodeficiency Virus Infected and Uninfected Men (from the Multicenter AIDS Cohort Study)Michael I Brener, Wendy S Post, Sabina A Haberlen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 15, 2021
Longitudinal Changes in Sex Hormone-Binding Globulin in Men With HIVJenny Pena Dias, Sabina A Haberlen, Adrian S Dobs, et al.
Clinical Endocrinology|September 26, 2020
Sociodemographic, lifestyle and medical influences on serum testosterone and sex hormone-binding globulin in men from UK BiobankBu B Yeap, Ross J Marriott, Leen Antonio, et al.
Journal of Diabetes|June 30, 2012
Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo-controlled 54-week trial in patients with type 2 diabetesAdrian S Dobs, Barry J Goldstein, Pablo Aschner, et al.
Mayo Clinic Proceedings|June 18, 2016
Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus ResolutionsAbraham Morgentaler, Michael Zitzmann, Abdulmaged M Traish, et al.
International Journal of Clinical Practice|October 25, 2016
Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME)Mario Maggi, Frederick C W Wu, Thomas H Jones, et al.
Clinical Cardiology|January 24, 2003
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemiaJonathan Isaacsohn, Donald Hunninghake, Helmut Schrott, et al.
Mayo Clinic Proceedings|June 26, 2016
Adult-Onset HypogonadismMohit Khera, Gregory A Broderick, Culley C Carson, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Journal of Acquired Immune Deficiency Syndromes (1999)|June 20, 2015
Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected MenKerunne S Ketlogetswe, Rebeccah McKibben, Lisa P Jacobson, et al.
AIDS (London, England)|January 10, 2014
Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected menKerunne S Ketlogetswe, Wendy S Post, Xiuhong Li, et al.
The American Journal of Cardiology|February 3, 2016
Comparison of Insulin Resistance to Coronary Atherosclerosis in Human Immunodeficiency Virus Infected and Uninfected Men (from the Multicenter AIDS Cohort Study)Michael I Brener, Wendy S Post, Sabina A Haberlen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 15, 2021
Longitudinal Changes in Sex Hormone-Binding Globulin in Men With HIVJenny Pena Dias, Sabina A Haberlen, Adrian S Dobs, et al.
Clinical Endocrinology|September 26, 2020
Sociodemographic, lifestyle and medical influences on serum testosterone and sex hormone-binding globulin in men from UK BiobankBu B Yeap, Ross J Marriott, Leen Antonio, et al.
Journal of Diabetes|June 30, 2012
Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo-controlled 54-week trial in patients with type 2 diabetesAdrian S Dobs, Barry J Goldstein, Pablo Aschner, et al.
Mayo Clinic Proceedings|June 18, 2016
Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus ResolutionsAbraham Morgentaler, Michael Zitzmann, Abdulmaged M Traish, et al.
International Journal of Clinical Practice|October 25, 2016
Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME)Mario Maggi, Frederick C W Wu, Thomas H Jones, et al.
Clinical Cardiology|January 24, 2003
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemiaJonathan Isaacsohn, Donald Hunninghake, Helmut Schrott, et al.
Mayo Clinic Proceedings|June 26, 2016
Adult-Onset HypogonadismMohit Khera, Gregory A Broderick, Culley C Carson, et al.
Pageof 12